Current Opinion in Rheumatology

(ISSN: 1040-8711, 1531-6963)

Mission Statement

A high impact review journal which boasts an international readership, Current Opinion in Rheumatology offers a broad-based perspective on the most recent and exciting developments within the field of rheumatology. Published bimonthly, each issue features insightful editorials and high quality invited reviews covering two or three key disciplines which include vasculitis syndromes, rehabilitation medicine in rheumatic diseases, crystal deposition diseases and rheumatoid arthritis. Each discipline introduces world renowned guest editors to ensure the journal is at the forefront of knowledge development and delivers balanced, expert assessments of advances from the previous year.

Contact Information

Publisher contact information is available at: http://journals.lww.com/co-rheumatology/pages/aboutthejournal.aspx

Subscription and Reprint Information

Subscription information is available at: http://journals.lww.com/co-rheumatology/_layouts/1033/oaks.journals/subscriptionservices.aspx

Reprint information is available at: http://journals.lww.com/co-rheumatology/_layouts/1033/oaks.journals/reprintsmedicine.aspx

Editorial Advisory Board

Editor: Cornelia M Weyand, MD
c/o Current Opinion in Rheumatology
Lippincott Williams & Wilkins
530 Walnut Street
Philadelphia, PA 19106
215 521 8488-Fax

Author Guidelines

Instructions for authors are available at: http://journals.lww.com/co-rheumatology/Pages/informationforauthors.aspx

Copyright

Copyright Information is available at: http://journals.lww.com/co-rheumatology/_layouts/1033/oaks.journals/rightsandpermissions.aspx

Disclaimer

The contents of this site include information relating to general principals of medical care that should not be construed as specific instructions for individual patients. Application of this information in a particular situation remains the professional responsibility of the practitioner. Lippincott Williams & Wilkins assumes no liability or responsibility for any errors or omissions in such information. Some drugs and medical devices presented in this publication have Food and Drug Administration (FDA) clearance for limited use in restricted research settings. It is the responsibility of the health care provider to ascertain the FDA status of each drug or device planned for use in their clinical practice. Any information posted to discussion forums (moderated and un moderated) is for informational purposes only. We are not responsible for the information or the result of its practice.

Journal Information